Global Contrast Media Market generated revenue of US$ 5,374.3 Million in 2022 and is account to reach US$ 7,452.0 Million by 2031 at a CAGR of 3.9% during the forecasted period, 2023-2031.
Contrast media, used in medical imaging procedures, enhance visibility and aid in diagnosing diseases. The market is influenced by increasing diagnostic imaging procedures globally, driven by aging populations and rising chronic diseases. Techniques like X-rays, CT scans, MRI, and ultrasound rely on contrast media to improve visualization. Technological advancements in imaging modalities, such as dual-energy CT and high-resolution MRI, require contrast media with higher iodine concentrations, which drives demand along with innovations in imaging equipment like digital X-ray systems.
The preference for minimally invasive procedures has fueled the contrast media market. These procedures offer benefits like reduced discomfort and faster recovery. Contrast media play a vital role in interventional radiology and cardiology, enhancing blood vessel visibility. The rising prevalence of cardiovascular disorders, cancer, and neurological conditions increases the demand for contrast media. Diagnostic imaging procedures aid in detection, monitoring, and treatment planning for these diseases.
North America dominates the contrast media market, followed by Europe, while the Asia-Pacific region is expected to grow. Urbanization, increased disposable incomes, rising healthcare expenditure, and improving infrastructure contribute to this growth.
Stringent regulatory requirements for safety and efficacy are imposed on the contrast media market. Compliance with these standards is crucial for market players to ensure product safety and obtain regulatory approvals.
To Get more Insights, Request A Free Sample
The rising demand for medical imaging procedures drives the demand for contrast media. Medical imaging techniques like X-rays, CT scans, MRI, and ultrasound rely on contrast media to enhance image visibility for accurate diagnosis and monitoring.
Chronic diseases significantly contribute to the demand for medical imaging. Cardiovascular diseases, the leading cause of global deaths, utilize imaging techniques such as CT angiography and cardiac MRI. Cancer diagnosis, staging, and treatment monitoring heavily rely on imaging modalities like CT scans, MRI, and PET scans, with approximately 19.3 million new cancer cases and 10 million cancer-related deaths in 2021. Neurological disorders, including stroke and neurodegenerative diseases, are diagnosed and monitored using MRI and CT scans. These disorders accounted for 16.8% of global deaths and 10.2% of global disability-adjusted life years (DALYs) in 2021.
The prevalence of chronic diseases and the need for accurate diagnosis and monitoring drive the growing demand for contrast media in the healthcare industry. The increasing number of imaging procedures highlights the significance of contrast media in enabling precise medical imaging for effective disease management.
Imaging technique utilize contrast media (CM) to feature the varieties between body tissues on pictures. The ideal contrast medium ought to be capable of sustaining extremely high concentrations in the tissue without causing any adverse effects. Unfortunately, this has not been possible up until this point, and every CM has negative effects. The effects of these chemicals can be mild, moderate, or severe. The different difference media make different side impacts. Rashes, skin redness, and swelling are the most common side effects, sometimes accompanied by nausea, vomiting, and dizziness.
Acute adverse reactions may occur following the use of agents based on iodine, gadolinium, and ultrasound. A small percentage of acute adverse reactions appear to be genuine allergic reactions, while others are the result of hypersensitivity or chemotoxicity.
Patients who have previously experienced a moderate or severe reaction are more likely to experience another reaction when given contrast medium again. Patients who have allergies in the past are more likely to have problems. Contrast agent side effects rarely result in life-threatening reactions. Contrast-induced nephropathy (CIN) is a known side effect of using intravenous or intra-arterial contrast material.
The global contrast media market is categorized into different types, including iodine, barium-sulfate, gadolinium, microbubbles, and others. Among these types, iodine held the largest market share in 2022.
Iodine-based contrast media are widely used in diagnostic imaging procedures such as X-rays, computed tomography (CT) scans, and angiograms. These contrast media enhance the visibility and clarity of images, aiding physicians in the diagnosis of various diseases. The demand for iodine in the contrast media market is closely tied to the global number of diagnostic imaging procedures. As the demand for diagnostic imaging procedures and the aging population worldwide continue to rise, the demand for iodine-based contrast media is expected to increase. Advanced imaging techniques such as dual-energy CT and spectral imaging, which require higher iodine concentrations for optimal image quality, will further drive the demand for iodine in the contrast media market.
The global contrast media market is segmented based on formulation into liquid, tablet, powder, and paste. Among these formulations, the liquid segment dominated the market share in 2022 and is expected to maintain its dominance in the forecast period.
Liquid contrast media improve the contrast between different tissues and organs, facilitating the identification and classification of specific medical conditions by healthcare professionals. Liquid formulations are preferred over other forms of contrast media, such as oral or rectal administration, due to their ability to produce more precise and accurate imaging results. However, factors like safety, efficacy, and cost also influence the choice of contrast media formulation. Liquid contrast media find extensive use in various diagnostic procedures, aiding medical professionals in the identification and diagnosis of medical conditions. Therefore, the demand for liquid contrast media is expected to grow steadily in the forecast period.
The global contrast media market is segmented based on the route of administration into oral route, rectal route, intravenous route, intramuscular route, intra-arterial, intradermal, and others. The oral route segment accounted for the largest market share in 2022.
The oral route of administration is preferred by many patients due to its less invasive nature compared to other routes. Oral contrast media are available in a wide range of forms, are generally more affordable, and easily accessible. Moreover, the oral route is considered safe with fewer side effects compared to other routes of administration. The awareness and acceptance of the oral route in the contrast media market are expected to continue growing in the coming years. In addition to the oral route, the intravenous route is frequently used for contrast media administration, especially in cases where rapid or dynamic imaging is required, such as emergency radiology or in patients with impaired renal function who cannot tolerate oral or rectal contrast.
The global contrast media market is categorized based on modality into X-Ray, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, and Others. The X-Ray segment held the highest market share in 2022.
Factors such as population growth, aging populations, improved access to healthcare, rising demand for diagnostic imaging procedures, increased prevalence of chronic diseases, and technological advancements contribute to the demand for X-ray imaging procedures and contrast media. Iodinated contrast media are preferred for X-ray imaging due to their ability to produce high-quality images and comparative affordability. The demand for X-ray imaging and contrast media is expected to remain strong in the forecast period, especially with the adoption of new technologies like digital X-ray and computed tomography (CT) scanners. However, factors such as safety concerns, reimbursement policies, and regulatory requirements may influence the future demand and growth of the market.
The global contrast media market is segmented based on indication into cardiovascular disorders, cancer, gastrointestinal disorders, neurological disorders, nephrological disorders, musculoskeletal disorders, and others. The cardiovascular disorders segment held the largest market share in 2022 and is anticipated to maintain its lead throughout the forecast period.
Diagnostic imaging procedures that use contrast media are often required for patients with cardiovascular disorders, as these conditions contribute significantly to morbidity and mortality worldwide. Contrast media are particularly necessary for cardiovascular imaging procedures that involve visualizing blood vessels, as they enhance the visibility of these challenging-to-see structures. The detection and treatment of cardiovascular diseases rely heavily on the use of contrast media, driving the high demand in the cardiovascular disorders segment.
The global contrast media market is segmented based on application into radiology, interventional radiology, interventional cardiology, and others. The interventional cardiology segment held the highest market share in 2022.
Contrast media play a crucial role in interventional cardiology procedures to improve the visibility of blood vessels during imaging, such as angioplasty and stent placement. In recent years, there has been a shift toward the use of non-ionic, low-osmolar contrast media in interventional cardiology, as they carry a lower risk of adverse effects like allergic reactions and kidney damage compared to high-osmolar contrast media. The demand for low-osmolar contrast media is expected to increase over time, leading to innovation and growth in this market segment. Furthermore, the growing demand for minimally invasive procedures and the shift toward low-osmolar contrast agents are anticipated to fuel the growth and innovation in this market segment in the coming years.
The global contrast media market is segmented based on end users into hospitals, diagnostic imaging centers, clinics, and others. The hospitals segment accounted for the largest market share in 2022.
Hospitals have a diverse range of imaging devices and cater to a wide range of patients with various medical conditions, some of which require imaging studies using contrast media. Hospitals also participate in clinical trials and research that may involve the use of contrast agents. Diagnostic imaging facilities are another important end user of contrast media. These facilities specialize in medical imaging and may offer a wider variety of imaging modalities compared to hospitals. Some patients prefer diagnostic imaging centers due to their specialized equipment and staff trained in the use of contrast media. Clinics or outpatient facilities, especially for standard imaging procedures like X-rays and CT scans, are also significant end users of contrast media.
To Understand More About this Research: Request A Free Sample
North America currently dominates the global contrast media market and is projected to maintain its dominance in the coming years, holding more than 35% of the revenue share during the forecast period. Several factors contribute to this market dominance. Firstly, there is a rising demand for processed foods, including meat and protein supplements, in North America. This growing demand for Contrast Media-based products positively impacts the contrast media market. Moreover, the rapid growth of e-commerce in the region further fuels the market by increasing accessibility and availability of contrast media products. Additionally, there is a growing consumer awareness of pet food and an increase in pet ownership, leading to an expanded market for contrast media used in veterinary applications. Collectively, these factors contribute to the expansion of the contrast media market in North America.
In contrast, the Asia-Pacific region is expected to witness significant growth during the forecast period. This growth can be attributed to several factors. Firstly, there has been a notable shift toward a more urban lifestyle in developing economies in the region, leading to increased demand for contrast media products. Additionally, there is an increasing consumption of healthy diets in the Asia-Pacific region, driven by factors such as rising disposable incomes, growing awareness of health and wellness, and a focus on preventive healthcare. Athletes and fitness enthusiasts, in particular, contribute to the demand for protein-based diets and supplements, further driving the growth of the contrast media market in the region.
By Type
By Formulation
By Route of Administration
By Modality
By Indication
By Application
By End-User
By Region
| Report Attribute | Details |
|---|---|
| Market Size Value in 2022 | US$ 5,374.3 Million |
| Expected Revenue in 2031 | US$ 7,452.0 Million |
| Historic Data | 2018-2021 |
| Base Year | 2022 |
| Forecast Period | 2023-2031 |
| Unit | Value (USD Mn) |
| CAGR | 3.9% |
| Segments covered | By Type, By Formulation, By Route of Administration, By Modality, By Indication, By Application, By End User, By Region |
| Key Companies | Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Imaging SPA, Congruent Pharmachem Private Limited, GE Healthcare, Guerbet, iMAX, Lantheus Medical Imaging, Inc., Nano Therapeutics Pvt. Ltd., Novalek Pharmaceuticals Pvt. Ltd, Rege Imaging & Cine Films Private Limited, Stanex Drugs & Chemical Pvt. Ltd., Taejoon Pharm, Trivitron Healthcare Pvt. Ltd., YRP Group, Other Prominent Players |
| Customization Scope | Get your customized report as per your preference. Ask for customization |
The global contrast media market has been estimated to be USD 5,374.3 million in 2022 and is expected to grow at a CAGR of 3.9% during the forecast period.
The increasing investment & development of generic contrast media is creating an opportunity for market expansion.
Allergies and side effects due to contrast agents are hampering the market.
Based on type, the Global Contrast Media Market is segmented into Iodine, Barium-Sulfate, Gadolinium, Microbubbles, and Others. Among these, the Iodine segment is expected to continue growing during the forecast period.
In terms of modality, X-Ray holds a maximum market share of 43.9% of the market in 2022.
Increasing adoption of CT & MRI modalities are among the upcoming trends in the market.
The well-established healthcare infrastructure and high healthcare expenditure in North America contribute to the growth of the market in the region.
Contrast media are used in medical imaging procedures to enhance the visibility of internal body structures. These procedures are often performed in hospitals and clinics, and the pandemic has led to a decrease in the number of imaging procedures being performed due to reduced patient volumes and elective procedure cancellations. Thus, the market saw a decline in 2020.
Based on the formulation, liquid media is dominating the market since liquid contrast media are typically injected into the bloodstream through a vein, allowing for a rapid and uniform distribution of the contrast agent throughout the body.
Based on application, the interventional cardiology segment is expected to grow with a CAGR of 4.6%. Additionally, the increasing demand for minimally invasive procedures and the shift towards low-osmolar contrast agents are expected to further drive the growth and innovation in this market segment in the coming years.
The oral route segment held the largest share in 2022 in the contrast media market. The demand for the oral route has been increasing as it is less invasive than other routes and is typically less expensive & is widely available throughout.
Cardiovascular Disorders sub-segment of all the indications acquired the maximum share of the market in 2022.
Key players in the contrast media market include competitors such as Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Imaging SPA, Congruent Pharmachem Private Limited, GE Healthcare, Guerbet, iMAX, Lantheus Medical Imaging, Inc., Nano Therapeutics Pvt. Ltd., Novalek Pharmaceuticals Pvt. Ltd, Rege Imaging & Cine Films Private Limited, and other major players.
LOOKING FOR COMPREHENSIVE MARKET KNOWLEDGE? ENGAGE OUR EXPERT SPECIALISTS.
SPEAK TO AN ANALYST
.png)
Features | Type of License | |||
 Single User |   Multi User |  Corporate | ||
| e-Access | ✓ | ✓ | ✓ | |
User Sharing | 1 User Only | 2-6 Users | Unlimited within Company/Enterprise | |
⨉ | ⨉ | ✓ | ||
Free Customization | Up To 30 hrs work | Up To 60 hrs work | Up To 80 hrs work | |
Deliverable |
| ✓ | ✓ | ✓ |
| ⨉ | ✓ | ✓ | |
| ⨉ | ⨉ | ✓ | |
Analyst Support | 4 Month Post purchase | 7 Month Post purchase | One Year Post purchase | |
Free Report update in next update cycle | ⨉ | ⨉ | ✓ | |
Free Industry Update (Within 180 days) | ⨉ | ⨉ | ✓ | |
Benefit | Up to 20% off on next purchase | Up to 30% off on next purchase | Up to 40% off on next purchase | |
| Report ID: AA0523443 | Delivery: 2 to 4 Hours 
.svg)
